Latest DDD-exit: MTHFD2 inhibitor for AML treatment

SciLifeLab researcher Thomas Helleday (Karolinska Institutet) and his group have investigated the role folate metabolism enzyme (MTHFD2) plays in DNA replication and genomic stability of cancer cells. The researchers validates … Continue reading Latest DDD-exit: MTHFD2 inhibitor for AML treatment